Lilly are off again only one day after the announcement of the failure of solanezumab at CTAD

When will they learn protein plaques is not the answer!!!

>>>

http://www.fiercebiotech.com/biotech/after-ph3-failures-lilly-signs-new-alzheimer-s-drug-pact-astrazeneca